| Products and Services |
Categories |
Structure-based drug discovery and development to create a versatile, rich and sustainable pipeline of novel drugs for 7TM receptor (GPCR) targets for large therapeutic markets.
The core therapeutic focus of the company is metabolic disorders, including obesity, an area of obvious unmet medical need and increasing prevalence globally. Their lead compound, targeting treatment of obesity, is on its way to Phase IIa clinical studies and a further obesity compound will enter Phase I/II studies. |
|
Fields marked as * are mandatory
|
|
| *Message |
|
| Contact Details |
Fremtidsvej 3
Hørsholm
DK-2970
Denmark
Tel: 45-39-25-77-77 |
|
| *Request
Type |
|
| *Email |
|
| *First
Name |
|
| *Last
Name |
|
| Address 1 |
|
| Address 2 |
|
| City |
|
| State |
|
| *Country |
|
| Zip |
|
| *Organization |
|
| *Telephone |
|
| Extension |
|
| Designation |
|
| Other |
|
|
Industry |
|
|
Other |
|
Preferred
Method Of
Contact |
If Other
Specify
|
|
|
